Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05564403
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:56.925422+00:00
Published At
2026-04-13T00:00:00+00:00
Record Updated At
2026-04-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Biliary Tract Carcinoma", "Advanced Gallbladder Carcinoma", "Advanced Intrahepatic Cholangiocarcinoma", "Recurrent Biliary Tract Carcinoma", "Recurrent Gallbladder Carcinoma", "Recurrent Intrahepatic Cholangiocarcinoma", "Stage III Distal Bile Duct Cancer AJCC v8", "Stage III Gallbladder Cancer AJCC v8", "Stage III Hilar Cholangiocarcinoma AJCC v8", "Stage III Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IV Distal Bile Duct Cancer AJCC v8", "Stage IV Gallbladder Cancer AJCC v8", "Stage IV Hilar Cholangiocarcinoma AJCC v8", "Stage IV Intrahepatic Cholangiocarcinoma AJCC v8", "Unresectable Biliary Tract Carcinoma", "Unresectable Gallbladder Carcinoma", "Unresectable Intrahepatic Cholangiocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-13"
protocolSection.identificationModule.nctId
"NCT05564403"
protocolSection.identificationModule.officialTitle
"FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Biliary Tract Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Biliary Tract Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Hilar Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Hilar Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Biliary Tract Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Intrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.